Key Points
HYDERABAD, Nov 7 (Reuters) - Indian generic drugmaker Zydus Lifesciences Ltd (ZYDU.NS) reported a better-than-expected 53.3% jump in quarterly profit on Tuesday, led by the strong sales in the domestic market and the United States...
Consolidated net profit was 8.01 billion rupees ($96.2 million) in the quarter ended Sept 30, compared with 5.23 billion rupees a year earlier..
Analysts, on an average, expected a profit of 7.58 billion rupees, per LSEG data...
On Monday, unit Zydus Wellness Ltd (ZYDS.NS), which makes consumer brands, reported a more than 30% drop in second-quarter profit, hit by a one-off tax expense..
You might be interested in
'Post-it' maker 3M India's Q1 profit rises on robust demand
10, Aug, 233M India (TMIN.NS) reported an over 53% rise in first-quarter profit, aided by strong demand in its transportation and electronics and safety and industrial businesses.
Apple India FY23 revenue hits Rs 50,000-crore on strong premium play
29, Oct, 23This has been the fastest growth in net profit for Apple in India in over the last five years, which analysts attributed to higher share of sales of new generation devices where margins are more and there is reduction in component cost last fiscal.
India's Zydus Lifesciences more than doubles profit on US sales growth
11, Aug, 23Indian generic drugmaker Zydus Lifesciences Ltd (ZYDU.NS) said on Friday its profit more than doubled in the first quarter, driven by strong sales in its U.S market.
‘Post-it’ maker 3M India’s Q4FY23 profit rises 24% on strong demand
30, May, 233M India, which makes everything from 'Scotch' tape and 'Post-it' notes to power tools and medical products, has been raising prices to offset the hit from surging commodity costs.
Weak bike sales drag India's Bajaj Auto to Q2 revenue miss
18, Oct, 23India's Bajaj Auto (BAJA.NS) on Wednesday reported its slowest second-quarter revenue growth in three years and missed estimates as price hikes failed to offset a dip in overall sales volume.
India's Aurobindo Pharma posts jump in profit on strong overseas demand
10, Nov, 23HYDERABAD (Reuters) - India's Aurobindo Pharma Ltd reported a better-than-expected 84.9% rise in second-quarter profit on Thursday, driven by strong sales in core markets Europe and the United States
Apple’s India sales near $6 billion as CEO Tim Cook begins retail push
17, Apr, 23Revenue in India grew by nearly 50%, from $4.1 billion a year earlier, according to a person familiar with the matter, who asked not to be named as the information is not public.
Godrej Properties sees 15% rise in FY24 bookings value after Q4 profit jump
03, May, 23The Godrej Group-owned firm's consolidated net profit rose to 4.12 billion rupees ($50.34 million), from 2.60 billion rupees a year earlier, aided by strong sales and robust demand for housing.
India's top drugmaker Sun Pharma beats Q2 profit view
01, Nov, 23Sun Pharmaceutical Industries (SUN.NS), India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday, driven by strong sales in its domestic and U.S. formulation businesses.
Maruti Suzuki India's Q2 profit jumps 80% on SUV demand
27, Oct, 23Maruti Suzuki India (MRTI.NS), the country's top carmaker by sales, on Friday reported a higher quarterly profit that smashed estimates, as strong demand for its sport utility vehicles (SUVs) and cooling input costs boosted margins.